Buscar
Mostrando ítems 1-10 de 191
Effectiveness of commercial inhibitors against subtype F HIV-1 protease
(TAYLOR & FRANCIS LTD, 2009)
Subtype F wild type HIV protease has been kinetically characterized using six commercial inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir) commonly used for HIV/AIDS treatment, as well as ...
Antiretroviral Therapy for HIV-2 Infection in Non-Endemic Regions
Human immunodeficiency virus type 2 (HIV-2) was isolated in AIDS patients in 1986. Around 1-2 million people are infected worldwide. The virus is less transmissible than HIV-1, being sexual contacts the most frequent route ...
Alkyl Hydroxybenzoic Acid Derivatives that Inhibit HIV-1 Protease Dimerization
(Bentham Science Publ Ltd, 2012-09-01)
The therapeutic potential of gallic acid and its derivatives as anti-cancer, antimicrobial and antiviral agents is well known. We have examined the mechanism by which natural gallic acid and newly synthesized gallic acid ...
Alkyl Hydroxybenzoic Acid Derivatives that Inhibit HIV-1 Protease Dimerization
(Bentham Science Publ Ltd, 2012-09-01)
The therapeutic potential of gallic acid and its derivatives as anti-cancer, antimicrobial and antiviral agents is well known. We have examined the mechanism by which natural gallic acid and newly synthesized gallic acid ...
Alkyl Hydroxybenzoic Acid Derivatives that Inhibit HIV-1 Protease Dimerization
(Bentham Science Publ Ltd, 2014)
Diagnosis, antiretroviral therapy, and emergence of resistance to antiretroviral agents in HIV-2 infection: a review
(Brazilian Society of Infectious Diseases, 2003-02-01)
Human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) are the causative agents of AIDS. HIV-2 is prevalent at moderate to high rates in West African countries, such as Senegal, Guinea, Gambia, and Cape Verde. ...
Computer-assisted assessment of potentially useful non-peptide HIV-1 protease inhibitors
(Elsevier Science BvAmsterdamHolanda, 2012)
Usando a dinâmica molecular para avaliar o impacto que as mutações na protease do HIV-1 produzem na interação da proteína com o antirretroviral darunavir
(Universidade Federal do ParáBrasilInstituto de Ciências da SaúdeUFPAPrograma de Pós-Graduação em Química Medicinal e Modelagem Molecular, 2022)